Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Transact Technologies (TACT) Cash & Equivalents (2016 - 2025)

Transact Technologies (TACT) has disclosed Cash & Equivalents for 16 consecutive years, with $20.4 million as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents rose 41.95% to $20.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $20.4 million through Dec 2025, up 41.95% year-over-year, with the annual reading at $20.4 million for FY2025, 41.95% up from the prior year.
  • Cash & Equivalents hit $20.4 million in Q4 2025 for Transact Technologies, up from $20.0 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $20.4 million in Q4 2025 to a low of $3.9 million in Q2 2022.
  • Historically, Cash & Equivalents has averaged $12.3 million across 5 years, with a median of $11.5 million in 2023.
  • Biggest five-year swings in Cash & Equivalents: surged 1870.22% in 2021 and later plummeted 65.89% in 2022.
  • Year by year, Cash & Equivalents stood at $19.5 million in 2021, then crashed by 59.16% to $7.9 million in 2022, then surged by 55.06% to $12.3 million in 2023, then rose by 16.82% to $14.4 million in 2024, then skyrocketed by 41.95% to $20.4 million in 2025.
  • Business Quant data shows Cash & Equivalents for TACT at $20.4 million in Q4 2025, $20.0 million in Q3 2025, and $17.7 million in Q2 2025.